胃腸薬市場 : 2029年までの予測

Report Overview

The global market for Gastrointestinal Drugs estimated at US$ 40922.6 million in the year 2023, is projected to reach a revised size of US$ 53820 million by 2029, growing at a CAGR of 4.67% during the forecast period 2023-2029.

The North America market for Gastrointestinal Drugs is estimated to increase from $ 12575 million in 2023 to reach $ 16238 million by 2029, at a CAGR of 4.35% during the forecast period of 2023 through 2029.

The China market for Gastrointestinal Drugs is estimated to increase from $ 5988 million in 2023 to reach $ 8670 million by 2029, at a CAGR of 6.36% during the forecast period of 2023 through 2029.

The Europe market for Gastrointestinal Drugs is estimated to increase from $ 8712 million in 2023 to reach $ 11420 million by 2029, at a CAGR of 4.61 % during the forecast period of 2023 through 2029.

The global key manufacturers of Gastrointestinal Drugs include Takeda, Bausch Health, Abbvie, AstraZeneca, Teva, Bayer, Pfizer, Sun Pharma, etc. In 2022, the global top five players had a share approximately 40.67% in terms of revenue.

Report Includes

This report presents an overview of global market for Gastrointestinal Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 – 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Gastrointestinal Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Gastrointestinal Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca, Sanofi, Bayer, Pfizer, GSK, Teva, Zeria, Perrigo, and Boehringer Ingelheim, etc.

By Company       

             Takeda

             AstraZeneca

             Bayer

             Pfizer

             Sun Pharma

             Teva

             Zeria

             Perrigo

             Eisai Co.

             Abbvie

             Jiangzhong

             AOSAIKANG Pharma

             Luoxin Pharma

             LIVZON

             Huadong Pharmaceutical

             Bausch Health

Segment by Type

             Prescription Gastrointestinal Drug

             OTC Gastrointestinal Drug

Segment by Application

             Inflammatory Bowel Disease

             IBS Disease

             Peptic Ulcer

             GERD

             Other

Segment by Region

North America

             U.S.

             Canada

China

Asia (excluding China)

             Japan

             South Korea

             Southeast Asia

             India

             Australia

Europe

             Germany

             France

             UK

             Italy

             Russia

Middle East, Africa, Latin America

             Brazil

             Mexico

             Middle East

             Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Gastrointestinal Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Gastrointestinal Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE 1

1.1 Gastrointestinal Drugs Product Introduction 1

1.2 Market by Type 2

1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 2

1.2.2 Prescription Gastrointestinal Drug 3

1.2.3 OTC Gastrointestinal Drug 4

1.3 Market by Application 5

1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 5

1.3.2 Inflammatory Bowel Disease 7

1.3.3 IBS Disease 8

1.3.4 Peptic Ulcer 9

1.3.5 GERD 10

1.4 Assumptions and Limitations 10

1.5 Study Objectives 11

1.6 Years Considered 12

2 EXECUTIVE SUMMARY 13

2.1 Global Gastrointestinal Drugs Revenue Estimates and Forecasts 2018-2029 13

2.2 Global Gastrointestinal Drugs Revenue by Region 14

2.2.1 Global Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029 14

2.2.2 Global Gastrointestinal Drugs Revenue by Region (2018-2023) 17

2.2.3 Global Gastrointestinal Drugs Revenue by Region (2024-2029) 17

2.2.4 Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029) 17

2.3 Global Gastrointestinal Drugs Sales Estimates and Forecasts 2018-2029 19

2.4 Global Gastrointestinal Drugs Sales by Region 19

2.4.1 Global Gastrointestinal Drugs Sales by Region: 2018 VS 2022 VS 2029 19

2.4.2 Global Gastrointestinal Drugs Sales by Region (2018-2023) 20

2.4.3 Global Sales Gastrointestinal Drugs by Region (2024-2029) 20

2.4.4 Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029) 21

2.5 North America 22

2.6 Europe 23

2.7 China 24

2.8 Asia (excluding China) 25

2.9 Middle East, Africa and Latin America 26

3 COMPETITION BY MANUFACTURERS 28

3.1 Global Gastrointestinal Drugs Sales by Manufacturers 28

3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023) 28

3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2018-2023) 29

3.1.3 Global Top Largest Manufacturers of Gastrointestinal Drugs in 2022 29

3.2 Global Gastrointestinal Drugs Revenue by Manufacturers 30

3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023) 30

3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023) 31

3.2.3 Global Top Companies by Gastrointestinal Drugs Revenue in 2022 32

3.3 Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022 33

3.4 Global Gastrointestinal Drugs Sales Price by Manufacturers (2018-2023) 33

3.5 Analysis of Competitive Landscape 34

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 34

3.5.2 Global Gastrointestinal Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3) 35

3.6 Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters 36

3.7 Global Key Manufacturers of Gastrointestinal Drugs, Founded Date 37

3.8 Mergers & Acquisitions, Expansion Plans 37

4 MARKET SIZE BY TYPE 40

4.1 Global Gastrointestinal Drugs Sales by Type 40

4.1.1 Global Gastrointestinal Drugs Historical Sales by Type (2018-2023) 40

4.1.2 Global Gastrointestinal Drugs Forecasted Sales by Type (2024-2029) 40

4.1.3 Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 40

4.2 Global Gastrointestinal Drugs Revenue by Type 41

4.2.1 Global Gastrointestinal Drugs Historical Revenue by Type (2018-2023) 41

4.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Type (2024-2029) 42

4.2.3 Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 42

4.3 Global Gastrointestinal Drugs Price by Type 43

4.3.1 Global Gastrointestinal Drugs Price by Type (2018-2023) 43

4.3.2 Global Gastrointestinal Drugs Price Forecast by Type (2024-2029) 43

5 MARKET SIZE BY APPLICATION 44

5.1 Global Gastrointestinal Drugs Sales by Application 44

5.1.1 Global Gastrointestinal Drugs Historical Sales by Application (2018-2023) 44

5.1.2 Global Gastrointestinal Drugs Forecasted Sales by Application (2024-2029) 44

5.1.3 Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 45

5.2 Global Gastrointestinal Drugs Revenue by Application 46

5.2.1 Global Gastrointestinal Drugs Historical Revenue by Application (2018-2023) 46

5.2.2 Global Gastrointestinal Drugs Forecasted Revenue by Application (2024-2029) 47

5.2.3 Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 47

5.3 Global Gastrointestinal Drugs Price by Application 49

5.3.1 Global Gastrointestinal Drugs Price by Application (2018-2023) 49

5.3.2 Global Gastrointestinal Drugs Price Forecast by Application (2024-2029) 49

6 NORTH AMERICA 50

6.1 North America Gastrointestinal Drugs Market Size by Type 50

6.1.1 North America Gastrointestinal Drugs Sales by Type (2018-2029) 50

6.1.2 North America Gastrointestinal Drugs Revenue by Type (2018-2029) 51

6.2 North America Gastrointestinal Drugs Market Size by Application 52

6.2.1 North America Gastrointestinal Drugs Sales by Application (2018-2029) 52

6.2.2 North America Gastrointestinal Drugs Revenue by Application (2018-2029) 53

6.3 North America Gastrointestinal Drugs Market Size by Country 55

6.3.1 North America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 55

6.3.2 North America Gastrointestinal Drugs Revenue by Country (2018-2029) 55

6.3.3 North America Gastrointestinal Drugs Sales by Country (2018-2029) 56

6.3.4 US 57

6.3.5 Canada 58

7 EUROPE 59

7.1 Europe Gastrointestinal Drugs Market Size by Type 59

7.1.1 Europe Gastrointestinal Drugs Sales by Type (2018-2029) 59

7.1.2 Europe Gastrointestinal Drugs Revenue by Type (2018-2029) 60

7.2 Europe Gastrointestinal Drugs Market Size by Application 61

7.2.1 Europe Gastrointestinal Drugs Sales by Application (2018-2029) 61

7.2.2 Europe Gastrointestinal Drugs Revenue by Application (2018-2029) 62

7.3 Europe Gastrointestinal Drugs Market Size by Country 63

7.3.1 Europe Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 63

7.3.2 Europe Gastrointestinal Drugs Revenue by Country (2018-2029) 64

7.3.3 Europe Gastrointestinal Drugs Sales by Country (2018-2029) 65

7.3.4 Germany 66

7.3.5 France 67

7.3.6 UK 67

7.3.7 Italy 68

7.3.8 Russia 68

8 CHINA 69

8.1 China Gastrointestinal Drugs Market Size by Type 69

8.1.1 China Gastrointestinal Drugs Sales by Type (2018-2029) 69

8.1.2 China Gastrointestinal Drugs Revenue by Type (2018-2029) 70

8.2 China Gastrointestinal Drugs Market Size by Application 71

8.2.1 China Gastrointestinal Drugs Sales by Application (2018-2029) 71

8.2.2 China Gastrointestinal Drugs Revenue by Application (2018-2029) 72

9 ASIA (EXCLUDING CHINA) 74

9.1 Asia Gastrointestinal Drugs Market Size by Type 74

9.1.1 Asia Gastrointestinal Drugs Sales by Type (2018-2029) 74

9.1.2 Asia Gastrointestinal Drugs Revenue by Type (2018-2029) 75

9.2 Asia Gastrointestinal Drugs Market Size by Application 76

9.2.1 Asia Gastrointestinal Drugs Sales by Application (2018-2029) 76

9.2.2 Asia Gastrointestinal Drugs Revenue by Application (2018-2029) 77

9.3 Asia Gastrointestinal Drugs Market Size by Region 78

9.3.1 Asia Gastrointestinal Drugs Revenue by Region: 2018 VS 2022 VS 2029 78

9.3.2 Asia Gastrointestinal Drugs Revenue by Region (2018-2029) 79

9.3.3 Asia Gastrointestinal Drugs Sales by Region (2018-2029) 80

9.3.4 Japan 81

9.3.5 South Korea 82

9.3.6 Southeast Asia 82

9.3.7 India 83

9.3.8 Australia 83

10 MIDDLE EAST, AFRICA AND LATIN AMERICA 84

10.1 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Type 84

10.1.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2029) 84

10.1.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2029) 84

10.2 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Application 85

10.2.1 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2029) 85

10.2.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2029) 86

10.3 Middle East, Africa and Latin America Gastrointestinal Drugs Market Size by Country 88

10.3.1 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country: 2018 VS 2022 VS 2029 88

10.3.2 Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2029) 88

10.3.3 Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2029) 89

10.3.4 Brazil 91

10.3.5 Mexico 91

10.3.6 Middle East 92

10.3.7 Africa 92

11 CORPORATE PROFILE 93

11.1 Takeda 93

11.1.1 Takeda Company Information 93

11.1.2 Takeda Overview 93

11.1.3 Takeda Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 94

11.1.4 Takeda Gastrointestinal Drugs Product Descriptions 94

11.1.5 Takeda Recent Developments 95

11.2 AstraZeneca 97

11.2.1 AstraZeneca Company Information 97

11.2.2 AstraZeneca Overview 97

11.2.3 AstraZeneca Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 98

11.2.4 AstraZeneca Gastrointestinal Drugs Product Descriptions 98

11.2.5 AstraZeneca Recent Developments 98

11.3 Bayer 99

11.3.1 Bayer Company Information 99

11.3.2 Bayer Overview 100

11.3.3 Bayer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 100

11.3.4 Bayer Gastrointestinal Drugs Product Descriptions 101

11.3.5 Bayer Recent Developments 102

11.4 Pfizer 103

11.4.1 Pfizer Company Information 103

11.4.2 Pfizer Overview 103

11.4.3 Pfizer Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 104

11.4.4 Pfizer Gastrointestinal Drugs Product Descriptions 104

11.4.5 Pfizer Recent Developments 104

11.5 Sun Pharma 105

11.5.1 Sun Pharma Company Information 105

11.5.2 Sun Pharma Overview 106

11.5.3 Sun Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 106

11.5.4 Sun Pharma Gastrointestinal Drugs Product Descriptions 107

11.6 Teva 107

11.6.1 Teva Company Information 107

11.6.2 Teva Overview 107

11.6.3 Teva Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 108

11.6.4 Teva Gastrointestinal Drugs Product Descriptions 108

11.6.5 Teva Recent Developments 109

11.7 Zeria 110

11.7.1 Zeria Company Information 110

11.7.2 Zeria Overview 110

11.7.3 Zeria Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 111

11.7.4 Zeria Gastrointestinal Drugs Product Descriptions 111

11.7.5 Zeria Recent Developments 112

11.8 Perrigo 113

11.8.1 Perrigo Company Information 113

11.8.2 Perrigo Overview 113

11.8.3 Perrigo Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 114

11.8.4 Perrigo Gastrointestinal Drugs Product Descriptions 114

11.9 Eisai Co. 115

11.9.1 Eisai Co. Company Information 115

11.9.2 Eisai Co. Overview 116

11.9.3 Eisai Co. Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 116

11.9.4 Eisai Co. Gastrointestinal Drugs Product Descriptions 117

11.10 Abbvie 118

11.10.1 Abbvie Company Information 118

11.10.2 Abbvie Overview 118

11.10.3 Abbvie Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 119

11.10.4 Abbvie Gastrointestinal Drugs Product Descriptions 119

11.10.5 Abbvie Recent Developments 120

11.11 Jiangzhong 121

11.11.1 Jiangzhong Company Information 121

11.11.2 Jiangzhong Overview 122

11.11.3 Jiangzhong Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 123

11.11.4 Jiangzhong Gastrointestinal Drugs Product Descriptions 123

11.12 AOSAIKANG Pharma 124

11.12.1 AOSAIKANG Pharma Company Information 124

11.12.2 AOSAIKANG Pharma Overview 124

11.12.3 AOSAIKANG Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 126

11.12.4 AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions 126

11.13 Luoxin Pharma 127

11.13.1 Luoxin Pharma Company Information 127

11.13.2 Luoxin Pharma Overview 128

11.13.3 Luoxin Pharma Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 128

11.13.4 Luoxin Pharma Gastrointestinal Drugs Product Descriptions 129

11.14 LIVZON 130

11.14.1 LIVZON Company Information 130

11.14.2 LIVZON Overview 130

11.14.3 LIVZON Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 132

11.14.4 LIVZON Gastrointestinal Drugs Product Descriptions 133

11.15 Huadong Pharmaceutical 133

11.15.1 Huadong Pharmaceutical Company Information 133

11.15.2 Huadong Pharmaceutical Overview 134

11.15.3 Huadong Pharmaceutical Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 135

11.15.4 Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions 135

11.16 Bausch Health 136

11.16.1 Bausch Health Company Information 136

11.16.2 Bausch Health Overview 137

11.16.3 Bausch Health Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2018-2023) 137

11.16.4 Bausch Health Gastrointestinal Drugs Product Descriptions 138

11.16.5 Bausch Health Recent Developments 138

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 140

12.1 Gastrointestinal Drugs Industry Chain Analysis 140

12.2 Gastrointestinal Drugs Key Raw Materials 140

12.2.1 Key Raw Materials 140

12.2.2 Raw Materials Key Suppliers 141

12.3 Gastrointestinal Drugs Production Mode & Process 142

12.4 Gastrointestinal Drugs Sales and Marketing 143

12.4.1 Gastrointestinal Drugs Sales Channels 144

12.4.2 Gastrointestinal Drugs Distributors 145

12.5 Gastrointestinal Drugs Customers 147

13 GASTROINTESTINAL DRUGS MARKET DYNAMICS 150

13.1.1 Gastrointestinal Drugs Industry Trends 150

13.1.2 Gastrointestinal Drugs Market Drivers 151

13.1.3 Gastrointestinal Drugs Market Challenges 152

13.1.4 Gastrointestinal Drugs Market Restraints 153

14 KEY FINDINGS IN THE GLOBAL GASTROINTESTINAL DRUGS STUDY 154

15 APPENDIX 156

15.1 Research Methodology 156

15.1.1 Methodology/Research Approach 156

15.1.2 Data Source 159

15.2 Author Details 161

15.3 Disclaimer 164




Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) 2

Table 2. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) 5

Table 3. Global Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 15

Table 4. Global Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million) 17

Table 5. Global Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million) 17

Table 6. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2023) 17

Table 7. Global Gastrointestinal Drugs Revenue Market Share by Region (2024-2029) 18

Table 8. Global Gastrointestinal Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units) 19

Table 9. Global Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units) 20

Table 10. Global Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units) 20

Table 11. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2023) 21

Table 12. Global Gastrointestinal Drugs Sales Market Share by Region (2024-2029) 21

Table 13. Global Gastrointestinal Drugs Sales by Manufacturers (2018-2023) & (M Units) 28

Table 14. Global Gastrointestinal Drugs Sales Share by Manufacturers (2018-2023) 29

Table 15. Global Gastrointestinal Drugs Revenue by Manufacturers (2018-2023) & (US$ Million) 30

Table 16. Global Gastrointestinal Drugs Revenue Market Share by Manufacturers (2018-2023) 31

Table 17. Global Key Players of Gastrointestinal Drugs, Industry Ranking, 2021 VS 2022 33

Table 18. Gastrointestinal Drugs Price by Manufacturers (2018-2023) & (USD/Unit) 33

Table 19. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) 35

Table 20. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Drugs as of 2022) 35

Table 21. Global Key Manufacturers of Gastrointestinal Drugs, Manufacturing Base Distribution and Headquarters 36

Table 22. Global Key Manufacturers of Gastrointestinal Drugs, Founded Date 37

Table 23. Mergers & Acquisitions, Expansion Plans 37

Table 24. Global Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 40

Table 25. Global Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 40

Table 26. Global Gastrointestinal Drugs Sales Share by Type (2018-2023) 40

Table 27. Global Gastrointestinal Drugs Sales Share by Type (2024-2029) 41

Table 28. Global Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 41

Table 29. Global Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 42

Table 30. Global Gastrointestinal Drugs Revenue Share by Type (2018-2023) 42

Table 31. Global Gastrointestinal Drugs Revenue Share by Type (2024-2029) 42

Table 32. Gastrointestinal Drugs Price by Type (2018-2023) & (USD/Unit) 43

Table 33. Global Gastrointestinal Drugs Price Forecast by Type (2024-2029) & (USD/Unit) 43

Table 34. Global Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 44

Table 35. Global Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 44

Table 36. Global Gastrointestinal Drugs Sales Share by Application (2018-2023) 45

Table 37. Global Gastrointestinal Drugs Sales Share by Application (2024-2029) 45

Table 38. Global Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 46

Table 39. Global Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 47

Table 40. Global Gastrointestinal Drugs Revenue Share by Application (2018-2023) 47

Table 41. Global Gastrointestinal Drugs Revenue Share by Application (2024-2029) 48

Table 42. Gastrointestinal Drugs Price by Application (2018-2023) & (USD/Unit) 49

Table 43. Global Gastrointestinal Drugs Price Forecast by Application (2024-2029) & (USD/Unit) 49

Table 44. North America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 50

Table 45. North America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 50

Table 46. North America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 51

Table 47. North America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 51

Table 48. North America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 52

Table 49. North America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 52

Table 50. North America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 53

Table 51. North America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 54

Table 52. North America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 55

Table 53. North America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million) 55

Table 54. North America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million) 55

Table 55. North America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units) 56

Table 56. North America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units) 56

Table 57. Europe Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 59

Table 58. Europe Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 59

Table 59. Europe Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 60

Table 60. Europe Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 60

Table 61. Europe Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 61

Table 62. Europe Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 61

Table 63. Europe Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 62

Table 64. Europe Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 62

Table 65. Europe Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 63

Table 66. Europe Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million) 64

Table 67. Europe Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million) 64

Table 68. Europe Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units) 65

Table 69. Europe Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units) 65

Table 70. China Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 69

Table 71. China Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 69

Table 72. China Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 70

Table 73. China Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 70

Table 74. China Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 71

Table 75. China Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 71

Table 76. China Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 72

Table 77. China Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 72

Table 78. Asia Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 74

Table 79. Asia Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 74

Table 80. Asia Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 75

Table 81. Asia Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 75

Table 82. Asia Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 76

Table 83. Asia Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 76

Table 84. Asia Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 77

Table 85. Asia Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 77

Table 86. Asia Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 78

Table 87. Asia Gastrointestinal Drugs Revenue by Region (2018-2023) & (US$ Million) 79

Table 88. Asia Gastrointestinal Drugs Revenue by Region (2024-2029) & (US$ Million) 79

Table 89. Asia Gastrointestinal Drugs Sales by Region (2018-2023) & (M Units) 80

Table 90. Asia Gastrointestinal Drugs Sales by Region (2024-2029) & (M Units) 80

Table 91. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2018-2023) & (M Units) 84

Table 92. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Type (2024-2029) & (M Units) 84

Table 93. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2018-2023) & (US$ Million) 84

Table 94. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Type (2024-2029) & (US$ Million) 85

Table 95. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2018-2023) & (M Units) 85

Table 96. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Application (2024-2029) & (M Units) 85

Table 97. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2018-2023) & (US$ Million) 86

Table 98. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Application (2024-2029) & (US$ Million) 87

Table 99. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million) 88

Table 100. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2018-2023) & (US$ Million) 88

Table 101. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue by Country (2024-2029) & (US$ Million) 89

Table 102. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2018-2023) & (M Units) 89

Table 103. Middle East, Africa and Latin America Gastrointestinal Drugs Sales by Country (2024-2029) & (M Units) 90

Table 104. Takeda Company Information 93

Table 105. Takeda Description and Major Businesses 93

Table 106. Takeda Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 94

Table 107. Takeda Gastrointestinal Drugs Product Descriptions 94

Table 108. Takeda Recent Developments 95

Table 109. AstraZeneca Company Information 97

Table 110. AstraZeneca Description and Major Businesses 97

Table 111. AstraZeneca Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 98

Table 112. AstraZeneca Gastrointestinal Drugs Product Descriptions 98

Table 113. AstraZeneca Recent Developments 98

Table 114. Bayer Company Information 99

Table 115. Bayer Description and Major Businesses 100

Table 116. Bayer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 100

Table 117. Bayer Gastrointestinal Drugs Product Descriptions 101

Table 118. Bayer Recent Developments 102

Table 119. Pfizer Company Information 103

Table 120. Pfizer Description and Major Businesses 103

Table 121. Pfizer Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 104

Table 122. Pfizer Gastrointestinal Drugs Product Descriptions 104

Table 123. Pfizer Recent Developments 104

Table 124. Sun Pharma Company Information 105

Table 125. Sun Pharma Description and Major Businesses 106

Table 126. Sun Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 106

Table 127. Sun Pharma Gastrointestinal Drugs Product Descriptions 107

Table 128. Teva Company Information 107

Table 129. Teva Description and Major Businesses 107

Table 130. Teva Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 108

Table 131. Teva Gastrointestinal Drugs Product Descriptions 108

Table 132. Teva Recent Developments 109

Table 133. Zeria Company Information 110

Table 134. Zeria Description and Major Businesses 110

Table 135. Zeria Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 111

Table 136. Zeria Gastrointestinal Drugs Product Descriptions 111

Table 137. Zeria Recent Developments 112

Table 138. Perrigo Company Information 113

Table 139. Perrigo Description and Major Businesses 113

Table 140. Perrigo Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 114

Table 141. Perrigo Gastrointestinal Drugs Product Descriptions 114

Table 142. Eisai Co. Company Information 115

Table 143. Eisai Co. Description and Major Businesses 116

Table 144. Eisai Co. Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 116

Table 145. Eisai Co. Gastrointestinal Drugs Product Descriptions 117

Table 146. Abbvie Company Information 118

Table 147. Abbvie Description and Major Businesses 118

Table 148. Abbvie Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 119

Table 149. Abbvie Gastrointestinal Drugs Product Descriptions 119

Table 150. Abbvie Recent Developments 120

Table 151. Jiangzhong Company Information 121

Table 152. Jiangzhong Description and Major Businesses 122

Table 153. Jiangzhong Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 123

Table 154. Jiangzhong Gastrointestinal Drugs Product Descriptions 123

Table 155. AOSAIKANG Pharma Company Information 124

Table 156. AOSAIKANG Pharma Description and Major Businesses 124

Table 157. AOSAIKANG Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 126

Table 158. AOSAIKANG Pharma Gastrointestinal Drugs Product Descriptions 126

Table 159. Luoxin Pharma Company Information 127

Table 160. Luoxin Pharma Description and Major Businesses 128

Table 161. Luoxin Pharma Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 128

Table 162. Luoxin Pharma Gastrointestinal Drugs Product Descriptions 129

Table 163. LIVZON Company Information 130

Table 164. LIVZON Description and Major Businesses 130

Table 165. LIVZON Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 132

Table 166. LIVZON Gastrointestinal Drugs Product Descriptions 133

Table 167. Huadong Pharmaceutical Company Information 133

Table 168. Huadong Pharmaceutical Description and Major Businesses 134

Table 169. Huadong Pharmaceutical Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 135

Table 170. Huadong Pharmaceutical Gastrointestinal Drugs Product Descriptions 135

Table 171. Bausch Health Company Information 136

Table 172. Bausch Health Description and Major Businesses 137

Table 173. Bausch Health Gastrointestinal Drugs Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023) 137

Table 174. Bausch Health Gastrointestinal Drugs Product Descriptions 138

Table 175. Bausch Health Recent Developments 138

Table 176. Key Raw Materials Lists 140

Table 177. Raw Materials Key Suppliers Lists 141

Table 178. Gastrointestinal Drugs Distributors List 145

Table 179. Gastrointestinal Drugs Customers List 147

Table 180. Gastrointestinal Drugs Market Trends 150

Table 181. Gastrointestinal Drugs Market Drivers 151

Table 182. Gastrointestinal Drugs Market Challenges 152

Table 183. Gastrointestinal Drugs Market Restraints 153

Table 184. Research Programs/Design for This Report 156

Table 185. Key Data Information from Secondary Sources 159

Table 186. Key Data Information from Primary Sources 160

Table 187. QYR Business Unit and Senior & Team Lead Analysts 162



List of Figures

Figure 1. Gastrointestinal Drugs Product Picture 1

Figure 2. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2018-2029 (US$ Million) 2

Figure 3. Global Gastrointestinal Drugs Market Share by Type: 2022 3

Figure 4. Global Gastrointestinal Drugs Market Share by Type: 2029 3

Figure 5. Prescription Gastrointestinal Drug Product Picture 4

Figure 6. OTC Gastrointestinal Drug Product Picture 4

Figure 7. Global Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) 5

Figure 8. Global Gastrointestinal Drugs Market Share by Application: 2022 6

Figure 9. Global Gastrointestinal Drugs Market Share by Application: 2029 7

Figure 10. Inflammatory Bowel Disease 8

Figure 11. IBS Disease 9

Figure 12. Peptic Ulcer 9

Figure 13. GERD 10

Figure 14. Gastrointestinal Drugs Report Years Considered 12

Figure 15. Global Gastrointestinal Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029 13

Figure 16. Global Gastrointestinal Drugs Revenue 2018-2029 (US$ Million) 14

Figure 17. Global Gastrointestinal Drugs Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million) 15

Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2022 16

Figure 19. Global Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2029 16

Figure 20. Global Gastrointestinal Drugs Revenue Market Share by Region (2018-2029) 18

Figure 21. Global Gastrointestinal Drugs Sales 2018-2029 (M Units) 19

Figure 22. Global Gastrointestinal Drugs Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (M Units) 20

Figure 23. Global Gastrointestinal Drugs Sales Market Share by Region (2018-2029) 22

Figure 24. North America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 22

Figure 25. North America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 23

Figure 26. Europe Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 23

Figure 27. Europe Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 24

Figure 28. China Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 24

Figure 29. China Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 25

Figure 30. Asia (excluding China) Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 25

Figure 31. Asia (excluding China) Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 26

Figure 32. Middle East, Africa and Latin America Gastrointestinal Drugs Sales YoY (2018-2029) & (M Units) 26

Figure 33. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue YoY (2018-2029) & (US$ Million) 27

Figure 34. The Gastrointestinal Drugs Market Share of Top Largest Manufacturers Around the World in 2022 30

Figure 35. The Top Largest Manufacturers of Gastrointestinal Drugs in the World: Market Share by Gastrointestinal Drugs Revenue in 2022 32

Figure 36. Global Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 41

Figure 37. Global Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 43

Figure 38. Global Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 46

Figure 39. Global Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 48

Figure 40. North America Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 50

Figure 41. North America Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 51

Figure 42. North America Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 53

Figure 43. North America Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 54

Figure 44. North America Gastrointestinal Drugs Revenue Share by Country (2018-2029) 56

Figure 45. North America Gastrointestinal Drugs Sales Share by Country (2018-2029) 57

Figure 46. US Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 57

Figure 47. Canada Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 58

Figure 48. Europe Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 59

Figure 49. Europe Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 60

Figure 50. Europe Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 62

Figure 51. Europe Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 63

Figure 52. Europe Gastrointestinal Drugs Revenue Share by Country (2018-2029) 65

Figure 53. Europe Gastrointestinal Drugs Sales Share by Country (2018-2029) 66

Figure 54. Germany Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 66

Figure 55. France Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 67

Figure 56. UK Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 67

Figure 57. Italy Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 68

Figure 58. Russia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 68

Figure 59. China Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 69

Figure 60. China Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 70

Figure 61. China Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 72

Figure 62. China Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 73

Figure 63. Asia Gastrointestinal Drugs Sales Market Share by Type (2018-2029) 74

Figure 64. Asia Gastrointestinal Drugs Revenue Market Share by Type (2018-2029) 75

Figure 65. Asia Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 77

Figure 66. Asia Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 78

Figure 67. Asia Gastrointestinal Drugs Revenue Share by Region (2018-2029) 80

Figure 68. Asia Gastrointestinal Drugs Sales Share by Region (2018-2029) 81

Figure 69. Japan Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 81

Figure 70. South Korea Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 82

Figure 71. Southeast Asia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 82

Figure 72. India Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 83

Figure 73. Australia Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 83

Figure 74. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Market Share by Application (2018-2029) 86

Figure 75. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Market Share by Application (2018-2029) 87

Figure 76. Middle East, Africa and Latin America Gastrointestinal Drugs Revenue Share by Country (2018-2029) 89

Figure 77. Middle East, Africa and Latin America Gastrointestinal Drugs Sales Share by Country (2018-2029) 90

Figure 78. Brazil Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 91

Figure 79. Mexico Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 91

Figure 80. Middle East Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 92

Figure 81. Africa Gastrointestinal Drugs Revenue (2018-2029) & (US$ Million) 92

Figure 82. Gastrointestinal Drugs Value Chain 140

Figure 83. Gastrointestinal Drugs Production Process (Capsule) 142

Figure 84. Gastrointestinal Drugs Production Process (Injection) 143

Figure 85. Gastrointestinal Drugs Production Process (Tablet) 143

Figure 86. Channels of Distribution 144

Figure 87. Distributors Profiles 147

Figure 88. Bottom-up and Top-down Approaches for This Report 158

Figure 89. Data Triangulation 159

Figure 90. Key Executives Interviewed 161